NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MSICS Pharma

MSICS Pharma

Private
Ness ZionaHealthcare & Life Scienceshttps://www.msicspharma.com/

Last Round

Seed

May 6, 2026

Total Funding Raised

$7.2M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

MSICS Pharma is a biotechnology company developing medical-grade technology to grow and produce psilocybin for the treatment of mental health conditions such as PTSD, depression, and OCD.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

tRNA synthetase biologyimmunomodulatorsbiologicsinterstitial lung diseasesILDsfibrosisrare diseasesorphan diseasesclinical-stage biotechNeuropilin-2 modulatorNRP2 modulatorpulmonary sarcoidosisdrug developmentdrug licensingantibody therapysolid tumorsfusion protein

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MSICS Pharma Comps

Public and private peers based on sector, stage, and business model.

MSICS Pharma comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MSICS Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 6, 2026
SeedApr 5, 2026

MSICS Pharma Investors

Notable investors and investment history

MSICS Pharma investors
InvestorRounds
FUSIONSeed
GlenRock IsraelSeed
SGL AcquisitionsSeed
L& VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 6, 2026

    $3.6M round led by FUSION.

MSICS Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MSICS Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MSICS Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersNess Ziona
Year Founded2020
Last FundingMay 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.